INN:

Class:

mTOR inhibitors

Adapted from Capal J.K. & Franz D.N. Profile of everolimus in the treatment of tuberous sclerosis complex: an evidence-based review of its place in therapy. Neuropsychiatric disease and treatment. 2016 Aug; 12: 2165-2172. doi: 10.2147/NDT.S91248.

All content on this site is intended for healthcare professionals only. If you are a patient or carer, please visit the Lymphoma Coalition.